Dorsal root ganglion neurons and tyrosine hydroxylase--an intriguing association with implications for sensation and pain
- PMID: 26447702
- PMCID: PMC4727984
- DOI: 10.1097/j.pain.0000000000000381
Dorsal root ganglion neurons and tyrosine hydroxylase--an intriguing association with implications for sensation and pain
Abstract
Tyrosine hydroxylase (TH) is a rate-limiting enzyme broadly expressed in noradrenergic and dopaminergic neurons in the central nervous system [57,70]. TH is also expressed by peripheral sympathetic neurons [98] as well as by enteric neurons within the gut [81,84]. Over 30 years ago, TH was unexpectedly discovered in developing and adult rodent cranial and dorsal root ganglion (DRG) neurons. Today, TH-expressing DRG neurons are being re-discovered as a relevant subpopulation. This review addresses the emerging importance of TH-expressing DRG neurons in sensation and pain mechanisms, focusing specifically on: 1) their nature as C-low threshold mechanoreceptors (C-LTMRs); 2) their involvement in nociception/pain; and 3) their catecholaminergic phenotype.
Conflict of interest statement
Pablo R. Brumovsky declares no conflicts of interest.
Figures
, present;
, absent; —, not determined). TH-expressing DRG neurons exhibit distinctive neurochemical features, some of which appear to be dependent on target (e.g., compare CGRP expression between neurons innervating hairy skin and viscera). Although VGLUT2 expression remains to be confirmed in somata of TH-expressing DRG neurons projecting to hairy skin and viscera (δ), the presence of the transporter in nerve terminals in close apposition to hair follicles [8], and the fact that virtually all visceral DRG neurons express VGLUT2 [11,12], suggest that TH-expressing DRG neurons synthesize both VGLUT2 and VGLUT3. (B) The presence of enzymes associated with catecholamine synthesis and metabolism, including TH and associated molecules (NET-1), supports the existence of dopaminergic (1) or noradrenergic (2) phenotypes for TH-expressing DRG neurons (shading denotes enzymes and catecholamines present or secreted from DRG somata). Abbreviations: Cav3.2, T-type calcium channel Cav.3.2; Gfrα2, GDNF family receptor alpha-2; MRGPRs, mas related G-protein coupled receptors; NaV1.8/9, voltage gated sodium channel 1.8/9; NFH, neurofilament high; NtsR1, neurotensin receptor type 1; P2X3, P2X purinoceptor 3; Piezo2, Piezo-type mechanosensitive ion channel component 2; RET, rearranged in transformation proto-oncogene; SP, substance P; TAFA4, chemokine-like protein TAFA4; TrkA, Tropomyosin receptor kinase A; TRPA1, Transient receptor potential cation channel, member A1; VGLUT, vesicular glutamate transporter type; Y2R, neuropeptide tyrosine receptor, type 2.References
-
- Aghajanian GK, Bunney BS. Dopamine “autoreceptors”: pharmacological characterization by microiontophoretic single cell recording studies. Naunyn Schmiedebergs Arch Pharmacol. 1977;297:1–7. - PubMed
-
- Aira Z, Barrenetxea T, Buesa I, Gomez-Esteban JC, Azkue JJ. Synaptic upregulation and superadditive interaction of dopamine D2- and mu-opioid receptors after peripheral nerve injury. Pain. 2014;155:2526–33. - PubMed
-
- Baetge G, Schneider KA, Gershon MD. Development and persistence of catecholaminergic neurons in cultured explants of fetal murine vagus nerves and bowel. Development. 1990;110:689–701. - PubMed
-
- Bergquist F, Shahabi HN, Nissbrandt H. Somatodendritic dopamine release in rat substantia nigra influences motor performance on the accelerating rod. Brain Res. 2003;973:81–91. - PubMed
-
- Bertrand A, Weil-Fugazza J. Sympathectomy does not modify the levels of dopa or dopamine in the rat dorsal root ganglion. Brain Res. 1995;681:201–4. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
